Promoter hypermethylation has been shown to be responsible for silencing of DLEC1 in ovarian cancer and in nasopharyngeal carcinoma (Kwong et al, 2006, 2007) but there has been no comprehensive methylation analysis reported for lung cancer. The gene discussed is DLEC1; the disease is lung cancer.